BR112014026440A8 - análises, métodos e aparelhos para avaliação de disrupção de rna. - Google Patents
análises, métodos e aparelhos para avaliação de disrupção de rna.Info
- Publication number
- BR112014026440A8 BR112014026440A8 BR112014026440A BR112014026440A BR112014026440A8 BR 112014026440 A8 BR112014026440 A8 BR 112014026440A8 BR 112014026440 A BR112014026440 A BR 112014026440A BR 112014026440 A BR112014026440 A BR 112014026440A BR 112014026440 A8 BR112014026440 A8 BR 112014026440A8
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- optionally
- evaluation
- analysis
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44756—Apparatus specially adapted therefor
- G01N27/44791—Microapparatus
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
Abstract
abstract various embodiments are described herein related to an assay, method and apparatus for performing an rna disruption assay (rda) for cellular rna optionally in response to a cytotoxic treatment such as chemotherapy and/or radiation treatment. the method comprises obtaining at least one electropherogram dataset corresponding to a unique biological sample comprising the cellular rna at a time point, optionally during or after the treatment; determining values for features from at least two shifted regions of the at least one electropherogram dataset, the shifting being due to the treatment; and optionally determining an rda score based on a combination of the values of the features. 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261637676P | 2012-04-24 | 2012-04-24 | |
US201361806222P | 2013-03-28 | 2013-03-28 | |
PCT/CA2013/000408 WO2013159200A1 (en) | 2012-04-24 | 2013-04-24 | Assays, methods and apparatus for assessing rna disruption |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014026440A2 BR112014026440A2 (pt) | 2017-06-27 |
BR112014026440A8 true BR112014026440A8 (pt) | 2018-01-16 |
Family
ID=49482066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014026440A BR112014026440A8 (pt) | 2012-04-24 | 2013-04-24 | análises, métodos e aparelhos para avaliação de disrupção de rna. |
Country Status (10)
Country | Link |
---|---|
US (2) | US11031096B2 (pt) |
EP (2) | EP2841604A4 (pt) |
JP (1) | JP6279549B2 (pt) |
CN (1) | CN104640998B (pt) |
AU (1) | AU2013252445B2 (pt) |
BR (1) | BR112014026440A8 (pt) |
CA (1) | CA2871195C (pt) |
HK (1) | HK1207887A1 (pt) |
SG (1) | SG11201406865PA (pt) |
WO (1) | WO2013159200A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104640998B (zh) | 2012-04-24 | 2018-08-14 | Rna诊断公司 | 用于评估rna断裂的试验、方法和设备 |
AU2013354857B2 (en) * | 2012-12-03 | 2019-05-02 | Rna Diagnostics Inc. | Methods and kits for monitoring response to radiation therapies in cancer |
US10731222B2 (en) | 2013-10-04 | 2020-08-04 | Rna Diagnostics Inc. | RNA disruption assay for predicting survival |
WO2016069539A1 (en) * | 2014-10-27 | 2016-05-06 | Helix Nanotechnologies, Inc. | Systems and methods of screening with a molecule recorder |
US10855748B2 (en) * | 2015-09-30 | 2020-12-01 | IntegenX, Inc. | Command center |
EP3405896A4 (en) * | 2016-01-22 | 2019-09-25 | Otraces Inc. | SYSTEMS AND METHODS FOR ENHANCING DIAGNOSIS OF DISEASE |
WO2018163610A1 (ja) * | 2017-03-10 | 2018-09-13 | 株式会社島津製作所 | 電気泳動解析方法、電気泳動解析装置及び電気泳動解析プログラム |
CN108253894B (zh) * | 2018-02-06 | 2020-08-18 | 中原内配集团股份有限公司 | 一种气缸套表面凸起结构的检测方法 |
JP2022114705A (ja) * | 2021-01-27 | 2022-08-08 | 株式会社島津製作所 | マイクロチップ電気泳動装置 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6251247B1 (en) | 1998-04-01 | 2001-06-26 | Hitachi Chemical Co., Ltd. | Detection of degradation of RNA using microchannel electrophoresis |
US6873915B2 (en) | 2001-08-24 | 2005-03-29 | Surromed, Inc. | Peak selection in multidimensional data |
WO2003085374A2 (en) | 2002-04-02 | 2003-10-16 | Aclara Biosciences, Inc. | Multiplexed assays using electrophoretically separated molecular tags |
US20060259248A1 (en) * | 2002-07-01 | 2006-11-16 | Institut Pasteur | System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
AU2003288621A1 (en) | 2002-12-31 | 2004-07-22 | Pfizer Products Inc. | Rna bioassay |
EP1457573B1 (en) | 2003-03-04 | 2006-06-21 | PamGene B.V. | Method for integrated nucleic acid integrity assessment and analysis |
DE10315581B4 (de) | 2003-04-05 | 2007-06-28 | Agilent Technologies, Inc. (n.d.Ges.d.Staates Delaware), Palo Alto | Verfahren zur Qualitätsbestimmung von RNA-Proben |
WO2005090609A1 (en) | 2004-03-18 | 2005-09-29 | Arcturus Bioscience, Inc. | Determination of rna quality |
US8131473B1 (en) | 2004-05-20 | 2012-03-06 | Metabolon, Inc. | Data analysis methods for locating entities of interest within large, multivariable datasets |
WO2006052731A2 (en) | 2004-11-05 | 2006-05-18 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and prediction of treatment response |
EP1772522A1 (en) | 2005-10-04 | 2007-04-11 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Control of preservation by biomarkers |
WO2007053491A2 (en) | 2005-10-28 | 2007-05-10 | The Trustees Of Columbia University In The City Of New York | Method and kit for evaluating rna quality |
CA2698152C (en) | 2007-09-05 | 2018-08-14 | Laurentian University | Method of using tumour rna integrity to measure response to chemotherapy in cancer patients |
US9150909B2 (en) | 2008-08-29 | 2015-10-06 | Bio-Rad Laboratories, Inc. | Determination of the integrity of RNA |
CA2742324A1 (en) | 2008-10-30 | 2010-06-03 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Methods for assessing rna patterns |
US10590463B2 (en) | 2011-08-10 | 2020-03-17 | RNA Disgnostics Inc. | Diagnostic methods and kits for monitoring response to chemotherapy in ovarian cancer |
CN104640998B (zh) | 2012-04-24 | 2018-08-14 | Rna诊断公司 | 用于评估rna断裂的试验、方法和设备 |
AU2013354857B2 (en) | 2012-12-03 | 2019-05-02 | Rna Diagnostics Inc. | Methods and kits for monitoring response to radiation therapies in cancer |
-
2013
- 2013-04-24 CN CN201380033703.8A patent/CN104640998B/zh active Active
- 2013-04-24 EP EP13782579.0A patent/EP2841604A4/en not_active Ceased
- 2013-04-24 JP JP2015507311A patent/JP6279549B2/ja active Active
- 2013-04-24 BR BR112014026440A patent/BR112014026440A8/pt not_active Application Discontinuation
- 2013-04-24 US US14/396,309 patent/US11031096B2/en active Active
- 2013-04-24 CA CA2871195A patent/CA2871195C/en active Active
- 2013-04-24 SG SG11201406865PA patent/SG11201406865PA/en unknown
- 2013-04-24 AU AU2013252445A patent/AU2013252445B2/en active Active
- 2013-04-24 WO PCT/CA2013/000408 patent/WO2013159200A1/en active Application Filing
- 2013-04-24 EP EP21163749.1A patent/EP3907294A1/en active Pending
-
2015
- 2015-09-01 HK HK15108548.3A patent/HK1207887A1/xx unknown
-
2021
- 2021-06-04 US US17/339,368 patent/US20220028489A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2013252445A8 (en) | 2015-01-15 |
US20220028489A1 (en) | 2022-01-27 |
US20150154350A1 (en) | 2015-06-04 |
JP2015519887A (ja) | 2015-07-16 |
CN104640998A (zh) | 2015-05-20 |
EP2841604A4 (en) | 2016-01-06 |
CA2871195A1 (en) | 2013-10-31 |
AU2013252445B2 (en) | 2018-01-18 |
JP6279549B2 (ja) | 2018-02-14 |
BR112014026440A2 (pt) | 2017-06-27 |
EP2841604A1 (en) | 2015-03-04 |
HK1207887A1 (en) | 2016-02-12 |
WO2013159200A1 (en) | 2013-10-31 |
EP3907294A1 (en) | 2021-11-10 |
SG11201406865PA (en) | 2014-11-27 |
CA2871195C (en) | 2023-01-10 |
AU2013252445A1 (en) | 2014-12-04 |
US11031096B2 (en) | 2021-06-08 |
CN104640998B (zh) | 2018-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014026440A8 (pt) | análises, métodos e aparelhos para avaliação de disrupção de rna. | |
BR112018069849A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático | |
BR112016027475A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático | |
EA201692157A1 (ru) | Синтез двухцепочечных нуклеиновых кислот | |
BR112015001592A8 (pt) | análise de imagem e medidas de amostras biológicas | |
WO2014151006A3 (en) | Biomarkers and methods of treating pd-1 and pd-l1 related conditions | |
BR112014025384A8 (pt) | método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares | |
BR112014018970A8 (pt) | Dispositivos de coleta de amostra com agentes de estabilização sanguínea | |
EP3654036A3 (en) | Stomach cancer biomarker and detection method | |
MX2016013261A (es) | Metodo para la cuantificacion de huevos de parasitos en las heces. | |
MY187050A (en) | Cancer cell-specific antibody, anticancer agent, and cancer testing method | |
EP3216852A4 (en) | Method for introducing nucleic acid, method for detecting nucleic acid, method for analyzing biological component, array device for biological component assay, and kit for analyzing biological component | |
EP2637126A3 (en) | Method and apparatus for detecting vehicle | |
AU2017248682B2 (en) | Method for detecting and/or characterising tumour cells and associated apparatus | |
GB2531213A (en) | Systems and methods for high throughput analysis of conformation in biological entities | |
WO2014145870A3 (en) | Novel compositions, methods and kits for blood typing | |
MX2019002929A (es) | Biomarcadores de arn para angioedema hereditario. | |
IT201600073964A1 (it) | Nanointerruttore basato su nucleotidi e metodi per la rilevazione di anticorpi e altri analiti | |
BR112019005167A2 (pt) | método e kit para analisar uma amostra | |
WO2013166444A3 (en) | Biomarker analysis using scodaphoresis | |
PH12017501957A1 (en) | Herbicide-tolerant maize plant dbn9858, and nucleotide sequence and method for detecting same | |
CA3156351A1 (en) | ANALYTE MEASUREMENT SYSTEM | |
GB2542576A (en) | Method and kit of detecting the absence of micro-oranisms | |
EP2937421A3 (en) | Biomarker for predicting effect of an anti-C-met antibody | |
WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |